Known targets — ChEMBL curated mechanism
ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Promegestone. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 known ✓ | P03372 | 3/20 | 0.43 |
| ▸ | ESR2 known ✓ | Q92731 | 2/20 | 0.43 |
| ▸ | ADRB2 known ✓ | P07550 | 1/20 | 0.42 |
| ▸ | ADRA2B known ✓ | P18089 | 1/20 | 0.42 |
| ▸ | OPRK1 known ✓ | P41145 | 1/20 | 0.42 |
| ▸ | PGR | P06401 | 9/20 | 0.94 |
| ▸ | NR3C1 | P04150 | 9/20 | 0.56 |
| ▸ | AR | P10275 | 9/20 | 0.56 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.43 |
| ▸ | THRA | P10827 | 1/20 | 0.43 |
| ▸ | NR3C2 | P08235 | 2/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Promegestone SCHEMBL37770 | 0.97 | PGR (1.00) | PGRNR3C1ARESR1ESR2 | |
| Demegestone SCHEMBL28338894 | 0.89 | PGR (0.75) | PGRNR3C1ARESR1ESR2 | |
| Demegestone SCHEMBL1649297 | 0.87 | PGR (0.78) | PGRNR3C1ARESR1ESR2 | |
| Demegestone SCHEMBL6851326 | 0.87 | PGR (0.78) | PGRNR3C1ARESR1ESR2 | |
| Demegestone SCHEMBL146550 | 0.87 | PGR (0.78) | PGRNR3C1ARESR1ESR2 | |
| SCHEMBL13918130 | 0.85 | PGR (0.79) | PGRNR3C1ARESR1ESR2 | |
| SCHEMBL20959664 | 0.83 | PGR (0.75) | PGRNR3C1ARESR1ESR2 | |
| SCHEMBL19286040 | 0.82 | PGR (0.74) | PGRNR3C1ARESR1ESR2 | |
| Trimegestone SCHEMBL17906556 | 0.81 | PGR (0.72) | PGRNR3C1ARESR1ESR2 | |
| Trimegestone SCHEMBL3155792 | 0.81 | PGR (0.72) | PGRNR3C1ARESR1ESR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110251463-A | Lotion containing hormone | 贝朗医疗有限公司 | 2019-09-20 | — | — | CN | disclosed |
| CN-104136008-A | hormone-containing emulsion | BRAUN MELSUNGEN AG | 2014-11-05 | — | — | CN | disclosed |
| CN-104136007-A | Krill phospholipid-containing emulsions containing hormones | BRAUN MELSUNGEN AG | 2014-11-05 | — | — | CN | disclosed |